224 related articles for article (PubMed ID: 24589724)
41. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.
Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G
Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256
[TBL] [Abstract][Full Text] [Related]
42. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
43. Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.
Guillén-Gómez E; Bardají-de-Quixano B; Ferrer S; Brotons C; Knepper MA; Carrascal M; Abian J; Mas JM; Calero F; Ballarín JA; Fernández-Llama P
J Diabetes Res; 2018; 2018():6165303. PubMed ID: 29854824
[TBL] [Abstract][Full Text] [Related]
44. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy.
Yagame M; Suzuki D; Jinde K; Yano N; Naka R; Abe Y; Nomoto Y; Sakai H; Suzuki H; Ohashi Y
Intern Med; 1995 Jun; 34(6):463-8. PubMed ID: 7549125
[TBL] [Abstract][Full Text] [Related]
45. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
46. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
[TBL] [Abstract][Full Text] [Related]
47. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
48. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
Wu J; Chen YD; Yu JK; Shi XL; Gu W
Diabetes Res Clin Pract; 2011 Feb; 91(2):213-9. PubMed ID: 21237525
[TBL] [Abstract][Full Text] [Related]
49. Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Ruilope LM; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Ferreira AC; Pieper A; Kimmeskamp-Kirschbaum N; Bakris GL
Am J Nephrol; 2014; 40(6):572-81. PubMed ID: 25591469
[TBL] [Abstract][Full Text] [Related]
50. Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.
Siwy J; Ahonen L; Magalhães P; Frantzi M; Rossing P
Methods Mol Biol; 2020; 2067():287-306. PubMed ID: 31701458
[TBL] [Abstract][Full Text] [Related]
51. Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria.
Andersen S; Mischak H; Zürbig P; Parving HH; Rossing P
BMC Nephrol; 2010 Nov; 11():29. PubMed ID: 21040538
[TBL] [Abstract][Full Text] [Related]
52. Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.
Ahn HS; Kim JH; Jeong H; Yu J; Yeom J; Song SH; Kim SS; Kim IJ; Kim K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545899
[TBL] [Abstract][Full Text] [Related]
53. Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients.
Li L; Yang Y; Zhu X; Xiong X; Zeng L; Xiong S; Jiang N; Li C; Yuan S; Xu H; Liu F; Sun L
J Diabetes; 2020 Mar; 12(3):237-246. PubMed ID: 31602779
[TBL] [Abstract][Full Text] [Related]
54. Urinary proteomics in diabetes and CKD.
Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
[TBL] [Abstract][Full Text] [Related]
55. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy.
Masulli M; Mancini M; Liuzzi R; Daniele S; Mainenti PP; Vergara E; Genovese S; Salvatore M; Vaccaro O
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):358-64. PubMed ID: 18805683
[TBL] [Abstract][Full Text] [Related]
56. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
57. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
58. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.
Dong Z; Wang Y; Qiu Q; Zhang X; Zhang L; Wu J; Wei R; Zhu H; Cai G; Sun X; Chen X
Diabetes Res Clin Pract; 2016 Nov; 121():112-118. PubMed ID: 27693840
[TBL] [Abstract][Full Text] [Related]
59. Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.
Doi T; Moriya T; Fujita Y; Minagawa N; Usami M; Sasaki T; Abe H; Kishi S; Murakami T; Ouchi M; Ichien G; Yamamoto K; Ikeda H; Koezuka Y; Takamatsu N; Shima K; Mauer M; Nagai K; Tominaga T
Diabetes; 2018 May; 67(5):986-993. PubMed ID: 29490904
[TBL] [Abstract][Full Text] [Related]
60. FABP1 and FABP2 as markers of diabetic nephropathy.
Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
